437
Participants
Start Date
March 24, 2020
Primary Completion Date
August 30, 2027
Study Completion Date
August 30, 2027
Sonrotoclax
Film-coated tablets administered once daily at a dose as specified in the treatment arm
Zanubrutinib
320 mg daily administered as two 80-mg capsules twice a day (160 mg twice a day) or as four 80-mg capsules once a day (320 mg once a day)
Obinutuzumab
Given as an intravenous infusion administered per label.
Auckland City Hospital, Auckland
Concord Repatriation General Hospital, Concord
Orange Health Service (Central West Cancer Care Centre), Orange
Peter Maccallum Cancer Centre, Melbourne
The Alfred Hospital, Melbourne
St Vincents Hospital Melbourne, Fitzroy
Box Hill Hospital, Box Hill
Monash Health, Clayton
Pindara Private Hospital, Benowa
John Flynn Private Hospital, Tugun
Royal Adelaide Hospital, Adelaide
Flinders Medical Centre, Bedford PK
Linear Clinical Research, Nedlands
Wellington Regional Hospital (Ccdhb), Wellington
Ospedale Santa Maria Della Misericordia, Perugia
Hospital Clinic de Barcelona, Barcelona
Columbia University Medical Center, New York
Memorial Sloan Kettering Cancer Center Mskcc, New York
Upmc Hillman Cancer Center(Univ of Pittsburgh), Pittsburgh
Ospedale San Raffaele, Milan
Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda, Milan
Start Madrid Fundacion Jimenez Diaz, Madrid
Clinica Universidad de Navarra Pamplona, Pamplona
Hospital Universitario de Salamanca, Salamanca
Centroricerche Cliniche Di Verona Srl, Verona
Hospital Universitario Marques de Valdecilla, Santander
The James Cancer Hospital and Solove Research Institute At Ohio State University, Columbus
Azienda Unita Sanitaria Locale Di Ravenna, Ravenna
Mayo Clinic Rochester, Rochester
Northwestern University, Chicago
University of Kansas Medical Center Research Institute, Kansas City
University of Nebraska Medical Center, Omaha
Md Anderson Cancer Center, Houston
UCLA Hematologyoncology, Los Angeles
Fred Hutchinson Cancer Research Center, Seattle
Massachusetts General Hospital, Boston
John Theurer Cancer Center Hackensack University Medical Center, Hackensack
Universitatsklinikum Carl Gustav Carus An Der Technischen Universitat Dresden, Dresden
Fondazione Policlinico Universitario Agostino Gemelli, Roma
North Shore Hospital, Takapuna
Hospital de La Santa Creu I Sant Pau, Barcelona
Vall D Hebron Institute of Oncology Vhio, Barcelona
Ico H Duran I Reynals, Barcelona
The Leeds Teaching Hospitals Nhs Trust, Leeds
Lead Sponsor
BeiGene
INDUSTRY